Cue Health Reports Fourth Quarter 2023 Financial Results

Go back to Cue Health Reports Fourth Quarter 2023 Financial Results

BTIG Downgrades Cue Health Inc (HLTH) to Neutral

March 14, 2024 6:07 AM EDT

BTIG analyst Mark A. Massaro downgraded Cue Health Inc (NASDAQ: HLTH) from Buy to Neutral.

The analyst comments "While Cue Health has done a very good job of building a large 250k+ instrument installed base and driving significant costs out of its business (to the tune of ~$200M), we are downgrading Cue Health from Buy to Neutral. With... More

Cue Health Inc. (HLTH) Tops Q4 EPS by 11c, Beats on Revenue; Offers Q1 Revenue Guidance

March 13, 2024 4:02 PM EDT

Cue Health Inc. (NASDAQ: HLTH) reported Q4 EPS of ($0.32), $0.11 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $17.68 million.

Cue expects first quarter 2024 revenues in the range of $9 million to $11 million.

For... More